Top 50 Medical Device Startup Investors in Belgium in September 2025

Investor	Medical Device Belgium investments
Meusinvest (Noshaq)	5
PMV	5
Capricorn Partners	5
S.R.I.W.	5
Pierre Rigaux	4
Namur Invest	3
White Fund	3
WING by Digital Wallonia	3
Newton Biocapital	3
UI Investissement	2
Sambrinvest	2
TCD Capital (ex TheClubDeal)	2
Vives Louvain Technology Fund	2
Inventures SA	2
New Science Ventures	2
Spinventure	2
Spreds	2
GoBeyond	2
Amazon Alexa Fund	2
Kurma Partners	2
Qbic Fund	2
Theodorus III	2
imec.xpand	2
Sensinnovat	2
Boehringer Ingelheim Venture Fund	1
SoFi	1
EQT Life Sciences	1
New Rhein	1
Lumiares	1
EIC Fund	1
Thuja Capital	1
Invest BW	1
Eduardo Ronzano	1
Financière Spin-Off Luxembourgeoise	1
Carevolution	1
Pierre Drion	1
Delta Partners	1
Manuardeo	1
Flanders Future Techfund	1
SFPI-FPIM	1
Omega Funds	1
imec.istart Future Fund	1
Fonds Vives II (University of Louvain, UCL)	1
SHIGERU AG	1
LeanSquare	1
Fidimec	1
Parana Management	1
Invest Mons Borinage Centre	1
Elaia	1
Sofinex	1

Noshaq offers financial services to help businesses develop.

Investment focus

Biotechnology, Health Care, Medical
Series A, Seed, Funding Round
Belgium, France, Germany

Portfolio highlights

TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.

Do and dare company

Investment focus

Software, Biotechnology, Health Care
Series A, Seed, Series B
Belgium, United States, The Netherlands

Portfolio highlights

Nobi — Fall detection for the elderly at your home or in a residential care center with the smart Nobi lamp. Nobi ensures that you can be helped quickly.
Apideck — Apideck gives vertical SaaS companies one unified API to launch accounting integrations in weeks. The fastest way for developers to build integrations.
Swave Photonics — Swave develops Spatial Computing, Holography, holographic chips, and holograms in the HXR chip to create 3D augmented and virtual reality and HUD Heads Up Displays

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Investment focus

Biotechnology, Health Care, Software
Funding Round, Series B, Series A
Belgium, United States, The Netherlands

Portfolio highlights

InsectSense — MIMICKING HOW INSECTS SENSE | Biomimetic technology based on the sensing mechanism of insects. A deeptech platform that applies synthetic biology, microfluidics and is powered by machine learning.
Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.
Econic Technologies — At Econic, we are pioneering the transformation of CO2 into high-performance materials that shape a better future for all.

The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the SociÃ©tÃ© RÃ©gionaledâ€™Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Series A, Series B
Belgium, United States, Spain

Portfolio highlights

Univercells — We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.
Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
Santero Therapeutics — This is the homepage of the website

Pierre Rigaux

Investment focus

Sports, Medical Device
Seed, Pre-Seed, Convertible Note
Belgium

Portfolio highlights

MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.

Namur Invest Group provides companies with financing solutions in various forms adapted to their needs, to strengthen their financial.

Investment focus

Health Care, Medical Device, Auctions
Series A, Seed, Funding Round
Belgium

Portfolio highlights

Invineo — Invineo design and development of a "smart machine" for catering and hospitality professionals.
Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
iSTAR Medical — iSTAR Medical is a medtech company delivering breakthrough eye care solutions through minimally-invasive implants with bio-integration.

For game changers in medtech

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Series B
Belgium

Portfolio highlights

Axithra — Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.
Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.

W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).

Investment focus

Software, Health Care, Internet
Seed, Convertible Note, Series A
Belgium

Portfolio highlights

IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.

Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.

Investment focus

Biotechnology, Medical, Health Care
Series A, Funding Round, Seed
Belgium, Japan, France

Portfolio highlights

AdipoPharma — AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases.
AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.

Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.

Investment focus

Manufacturing, Software, Health Care
Private Equity, Series A, Seed
France, Spain, Canada

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Fizimed — Fizimed has made the choice to develop the EMY perineal probe with recognized health professionals. The probe is connected to a mobile app and associated with custom exercises. The probe captures the contractions of the perineal muscles in real time to allow the patient to do 5-minute exercises through fun games (jumping obstacles, jumping ...) sothat she remains motivated. The patient can follow her results as well as her progress in the application and unlock new universes according to the points obtained. Much of the effort of Fizimed's technical teams is focused on balancing a product, combining the quality and safety of a medical device, with a fun application to empower each woman. One goal: the simplicity of the product and the interface for home use.Beyond the product, the Fizimed team is committed to the fight against taboos related to urinary incontinence problems affecting one in ten women. She wants to "demystify" this topic so that every woman can find her adapted solution. An EMY community is being born on social networks in which the feminine hassles are put into images and discussed with humor, while talking about innovations that can simplify their daily lives.In summary, EMY by Fizimed is the connected and fun medical probe that allows women wishing to regain control of their perineum to do their home exercises. It was developed by a dynamic Alsatian start-up whose ambition is to remove taboos on a public health issue.
Fungu'it — A new generation of flavor ingredients for healthy, sustainable, and accessible food.

Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Series A, Series B
Belgium, France, Spain

Portfolio highlights

AdipoPharma — AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases.
AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

TheClubDeal is an investment holding and fund manager co-investing into SME’s and real estate projects. It provides facilitation of governance between non-executive shareholders and entrepreneurs. Its governance structure, including its charter of avoidance of conflict of interests, is therefore paramount to the adequate management of the Company.At TheClubDeal, we connect Investors and Entrepreneurs around promising investment opportunities. For each of these, we will invest ourselves and co-invest with a selected number of investors. We add value by processing strong applied governance principles, when selecting and managing our investments, and by gathering the necessary skills to successfully grow the businesses and real-estate projects we co-invest in. TheClubDeal is launching their second fund, a 50M € PRIVAK/PRICAF in H1 2021 with the mandate to invest in Belgian scale-ups in three sectors: Smart Living, Tech and Life Sciences.

Investment focus

Health Care, Biotechnology, Information Technology
Series A, Series B, Seed
Belgium, France

Portfolio highlights

Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
Inpulse — Inpulse is an automated supply management platform for restaurateurs.
Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.

Vives is an interregional seed and early stage technology multi-sector fund. The new fund, initiated by UCLouvain, is a unique European inter-university fund having access to world class innovations from leading EU top universities.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Funding Round
Belgium, France, United States

Portfolio highlights

BOTALYS — BOTALYS uses an innovative Biomimetic Indoor Farming technology to recreate the ideal wild conditions for rare botanicals to grow in. We develop pristine & potent botanical ingredients for the Nutraceutical and Cosmetic industries.
Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.

Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.

Investment focus

Health Care, Manufacturing, Biotechnology
Series A, Seed, Funding Round
Belgium, France, United Kingdom

Portfolio highlights

BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
Octave — A sustainable, cost-effective and reliable energy storage system with second-life batteries from electric vehicles.

New Science Ventures is a venture capital firm that focuses on investments in life sciences and information technology companies. They invest in early and late stage companies taking novel scientific approaches to address significant unmet needs, while creating order-of-magnitude improvements in performances. The company also invests in companiesusing science-based innovations to address market needs in life sciences such as pharmaceuticals, biologics, medical devices, diagnostics, and IT. The team of the company expertise in strategy and corporate planning, operations and cost management, and leadership development.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series D
United States, United Kingdom, Belgium

Portfolio highlights

Glydways — Glydways, formerly Wayfarer is a transportation technology and clean energy company based in South San Francisco, California. It specializes in the design, manufacture, installation, and operation of affordable autonomous transportation for low, medium, and extremely high-capacity needs.
Vuv Analytics — VUV Analytics was incorporated in Austin, TX in December 2009, as a spin-off from a semiconductor equipment company. The five founders bring with them critical and unique know-how related to the hardware, software, analysis, intellectual property, and marketing associated with VUV technologies. The team's past success in pioneering VUVreflectometry for use in the semiconductor metrology field yielded several key market wins and an extensive IP portfolio, including 32 issued patents and 12 pending patents.
Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.

Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège. It is headquartered in Angleur, Belgium.

Investment focus

Health Care, Biotechnology, Medical
Series A, Funding Round
Belgium

Portfolio highlights

Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.

We empower high-potential entrepreneurship and democratize venture capital. Discover promising start-ups & SMEs and invest alongside business angels.

Investment focus

Health Care, Information Technology, Food and Beverage
Series A, Seed, Series B
Belgium, France

Portfolio highlights

Opinum — What is Opinum Data Hub? Our Data Hub is a secured Cloud-based platform that allows energy and environmental actors to centralise, enhance, analyse, and share data.
Digiteal — Digiteal offers a wide range of services for e-invoice presentment, electronic payments and open banking.
NietsCo — NietsCo. is the home of Botaniets Gin 0.0%, a leading selection of alcohol-free products, carefully distributed to the world's best restaurants, concept stores, shops and consumers.

GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.

Investment focus

Information Technology, Medical, Software
Funding Round, Seed, Series A
Switzerland, Germany, United Kingdom

Portfolio highlights

LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
AVAtronics — AVA Active Noise Cancellation (ANC) Solution is a breakthrough in Audio Industry. AVA is the first and only TRUE WIDE-BAND ANC in the market capable of selectively cancelling all annoying noises we want to get rid of without compromising the quality of Music or speech.
Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.

The Amazon Alexa Fund is Amazon’s venture capital fund investing in artificial intelligence, frontier tech, voice, robotics, and digital health across consumer and enterprise. We invest in early- to growth-stage companies globally. To learn more, visit us at alexafund.com.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Series A, Series B
United States, United Kingdom, Canada

Portfolio highlights

Heyboss.xyz — Talking AIs that helps kids learn and play!
Heyboss — AI engineer for non-coders, backed by OpenAI. Get your personal AI engineer to build apps, websites and games without you writing any code.
IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Seed, Series B
France, Switzerland, Spain

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.

The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.

Investment focus

Biotechnology, Software, Health Care
Seed, Funding Round, Series A
Belgium

Portfolio highlights

Pleevi — AI powered smart charging to charge fleet more cost-efficient and cleaner on professional sites
Weavely — Design forms in Figma - publish with Weavely. We turn your visual ideas into interactive, web-based forms.
Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works

Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.

Investment focus

Health Care, Life Science, Medical
Funding Round, Seed, Series A
Belgium, Canada, France

Portfolio highlights

DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.

Expanding nanotechnology into business.

Investment focus

Semiconductor, Medical Device, Manufacturing
Seed, Series A, Series B
Belgium, United States, The Netherlands

Portfolio highlights

Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
Mojo Vision — Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today'smobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree.Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Sensinnovat

Investment focus

Medical, Diabetes, Health Care
Series A, Series B
Belgium

Portfolio highlights

Azalea Vision — Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders.
Indigo Diabetes — Revolutionizing the management of chronic disease.

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.

SoFi is a finance company that offers a range of lending and wealth management services. The company primarily caters to early-stage professionals and offers variable and fixed rate parent, personal, and MBA loans, mortgage refinancing, and more. They create modern financial products and services that help people borrow, save, spend, invest, andprotect their money better so that they can achieve financial independence and realize their ambitions from owning a home to saving for retirement, paying off their student loans, and more.It was founded in 2016 and is headquartered in San Francisco, California.

Investment focus

Apps, Biotechnology, Information Technology
Series A, Funding Round, Seed
Belgium, Brazil, United States

Portfolio highlights

PieSync — PieSync creates deep integrations between web applications focused on business users. Our goal: increasing your productivity drastically by combining the powers of your favorite cloud applications
Wage — Thanks for your interest in Wage.com - If you are interested in purchasing this domain, please click the button below to get in contact. Some Value Points for the domain: 1. Highly Aged (SEO Benefits) (Wage.com HAS BEEN ACTIVE SINCE 1996) 2. Highly Sought After (Value Appreciation) (
Indigo Diabetes — Revolutionizing the management of chronic disease.

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, The Netherlands, Switzerland

Portfolio highlights

Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer

New Rhein is a Philadelphia based healthcare venture capital firm focused on repurposed assets.

Investment focus

Medical, Biotechnology, Health Care
Series B, Series A, Seed
United States, Israel, Belgium

Portfolio highlights

Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
Corsair Pharma — Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.
Butterfly Medical — Butterfly, Butterfly Medical, BPH Treatment, BPH Office Procedure, Idan Geva, Minimally Invasive BPH, Prostate, Enlarged Prostate, Bening Prostate Hyperplasia, Urology

Guiding health technology towards a brighter future.

Investment focus

Software, Health Care, Manufacturing
Pre-Seed
Belgium

Portfolio highlights

Koios Care — Koios Care is a startup in the field of digital health. Their objective is to develop innovative and validated digital daily activity biomarkers in order to improve care while lowering costs.
Nuclivision — Nuclivision is a company of experts assisting businesses, doctors and clinics all along the imaging workflow

start-ups, SMEs, technology, co-investment

Investment focus

Biotechnology, Health Care, Information Technology
Pre-Seed, Seed, Funding Round
Germany, The Netherlands, Austria

Portfolio highlights

Filuta AI — Operationalized Composite Artificial Intelligence
Resistell AG — Resistell is a antibiotic resistance test.
iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.

Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Series A, Seed
The Netherlands, Belgium, United States

Portfolio highlights

Pan Cancer — Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer.
Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.

Invest BW is a funding program.

Investment focus

Health Care, AgTech, Medical
Series A, Seed, Series B
Belgium

Portfolio highlights

IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
Minagro — Minagro develops high-quality green products for crop care. Minagro conducts research activities in confirmed proprietary technologies from green and specialty chemistries.
Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.

Eduardo Ronzano is the Co-Founder and CEO of Kolet. He previously worked at The Bradery as a Pre-Seed Investor. Eduardo Ronzano attended ESCP Business School.

Investment focus

Software, E-Commerce, SaaS
Seed, Pre-Seed, Angel
France, United States, United Kingdom

Portfolio highlights

Kraaft — Kraaft.co is an instant messenger app dedicated to site monitoring for VRD public works trades: roads and various networks. Paris, Île-de-France in 2019.
Frak Labs — Manage your unified web identity, earn rewards, and interact seamlessly with partner websites using our passkey-first blockchain smart wallet.
Poolside — We are software's leading AI research lab.

Specializes in spin-off and spin-out investments.

Investment focus

Medical, Health Care, Medical Device
Series A
Belgium

Portfolio highlights

Synergia Medical — Synergia Medical aims at developing and commercializing next generation neurostimulation devices. It relies on a seasoned management team with extensive experience in developing implantable neurostimulators.In only three years time, the company became ISO13485 certified, created and sold an OEM external neurostimulator for a motorized amputeeprosthesis arm and developed its first version of the NAOS platform.Supported by private investors and public research grants, the company has quickly grown to a team of thirteen highly skilled multidisciplinary professionals.

Offers health consulting services

Investment focus

Health Care, mHealth, Therapeutics
Seed
Belgium, United States

Portfolio highlights

moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
Helpper — Helpper verbindt mensen die thuishulp zoeken voor dagelijkse taken, met hulpvaardige buurtbewoners die een centje willen bijverdienen.
Neuroventis — Neuroventis emboldening people with neurological disorders. Learn how our technology is changing the world of neurological care.

Pierre Drion - CEO @ Petercam

Investment focus

Biotechnology, Health Care, Life Science
Series A, Series B, Funding Round
Belgium

Portfolio highlights

A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Santero Therapeutics — This is the homepage of the website

Early stage VC investments and funding for start-ups / founders in Ireland.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
Ireland, United States, United Kingdom

Portfolio highlights

Imvizar — Transform your buildings, office spaces, visitor attractions, and parks with an immersive and visual storytelling experience using augmented reality. Discover unique ways to tell your story at Imvizar.
ZeroMission — ZeroMission is an electromobility and lead innovator in software development, and power-energy infrastructure.ZeroMission offers fleet management software to businesses that own and operate fleets of commercial electric vehicles (EVs).
MarketSizer — MarketSizer offers subscription-based competitive intelligence and market insights for SaaS vendors who want to strategically grow their business.

Manuardeo is an early stage investments focused VC firm.

Investment focus

Medical, Diabetes, Health Care
Series A, Series B
Belgium

Portfolio highlights

Indigo Diabetes — Revolutionizing the management of chronic disease.

Flanders Future Techfund operates as an investment firm.

Investment focus

Medical, Semiconductor, Clinical Trials
Seed
Belgium

Portfolio highlights

EDGX — EDGX, founded in 2023 in Ghent, is a Belgian Space Tech company developing high-speed edge computing units for satellites. Its NVIDIA-powered Sterna Computer and SpaceFeather software enable real-time, AI-driven on-orbit data processing for applications in communication, Earth observation, and intelligence.
Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.

The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.

Investment focus

Health Care, Biotechnology, Medical Device
Funding Round, Series B, Series A
Belgium, United States, France

Portfolio highlights

Cohabs — We create sustainable & community-driven shared homes around the world for young workers and interns. Join our community.
Univercells — We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.
Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
Alleviant Medical — Interventional therapy for congestive heart failure
Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.

imec.istart Future Fund is an independent early-stage venture capital fund.

Investment focus

Pre-Seed

Portfolio highlights

Karomia — Karomia is an efficient and engaging B2B SaaS solution supporting sustainability officers in conducting a Double Materiality Assessment (DMA) of their organization, as part of their ESG report.
IntelliProve — Supercharge your digital health solution with clinically-validated biomarker data from sophisticated facial scanning technology.
Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.

Fonds Vives II (University of Louvain, UCL)

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Seed
Belgium, United States

Portfolio highlights

Virovet — Antiviral drugs and thermostable vaccines for livestock
Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.

SHIGERU AG is a technology company that leverages technological innovation to enable a new way of life.

Investment focus

Natural Language Processing, Virtual Reality, Blockchain
Pre-Seed, Seed, Series A
United States, Japan, Belgium

Portfolio highlights

DR. PECKER INC. — DR. PECKER is AI & generative AI driven, smart clinics & health tech software solutions, platform and services provider. The industries the company tackles are augmented & immersive user experience in smart clinics & heath tech, medical research, humanity with Meta Verse & Multi Verse extensions.
RAI — RAI is a mixed reality, generative AI, metaverse, and multiverse software solutions, platforms, and services provider. The industries the company tackles are augmented workspaces, heath tech, media and streaming, humanity, XR/MR + AI, and Meta Verse
Thunderbirds — Fintech | XR/MR + AI | Metaverse & Multiverse

New Economy Startups Investor & Accelerator

Investment focus

Software, Music, Internet
Seed, Funding Round, Series A
Belgium, France, United States

Portfolio highlights

LinkByCar — Revolutionize fleet operations with LinkByCar. From real-time tracking to predictive maintenance, our advanced telematics solutions save time and reduce costs.
Bridge.audio — Bridge is for everyone working with music and audio. We provide private workspaces to manage, share, and connect better.
Base for music — Base for Music is the marketing solution specialized in fan acquisition, enabling you to achieve your growth goals and providing you with transparent data to measure your return on investment.

Fidimec is a Belgium-based venture capital firm that offers investment and incubation services for seed stage startups.

Investment focus

Industrial, Semiconductor, Medical
Funding Round, Series A, Seed
Belgium

Portfolio highlights

Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
Sentea — Sentea makes fibre optic Sensing affordable to the industry and enables continuous monitoring even in harsh environments.
MICLEDI Microdisplays — MICLEDI Microdisplays is an experienced executive in the semiconductor industry,

Parana Management

Investment focus

Medical, Diabetes, Health Care
Series A, Series B
Belgium

Portfolio highlights

Indigo Diabetes — Revolutionizing the management of chronic disease.

IMBC is particularly active in the agri-food, technology, and environmental sectors, with direct links to the ecosystems of the Mons Borinage region.

Investment focus

Farming, Training, Wellness
Seed, Pre-Seed, Series A
Belgium

Portfolio highlights

BiocSol — BiocSol focus on sustainable microbial-based crop protection.
iQrypto — Quantum technologies for a more secure world.
Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Series B
France, United States, Spain

Portfolio highlights

SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
Moments Lab — Newsbridge is a cloud platform for Media & Sports Rights-Holders. Index your content with AI. Build & Monetize your Media Asset Collections.
Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.

Sofinex is an investment comapny.

Investment focus

Wellness, Lifestyle, Health Care
Series A
Belgium

Portfolio highlights

Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.